Skip to main content
Retour
Watch Compare

MYRIAD GENETICS INC

Qualité des données : 100%
MYGN
NASDAQ Manufacturing Chemicals
4,35 €
▼ 0,09 € (-2,03%)
Cap. Boursière: 432,01 M
Prix
4,62 €
Cap. Boursière
432,01 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 4,53% annually over 5 years — modest growth
Debt/Equity of 0,32 — conservative balance sheet
Generating 1,80 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 6,09%

Croissance

Revenue Growth (5Y)
4,53%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)-1,56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-96,18%
En dessous de la moyenne du secteur (-53,58%)
ROIC-57,85%
Net Margin-44,38%
Op. Margin-46,96%

Sécurité

Debt / Equity
0,32
Au-dessus de la moyenne du secteur (0,30)
Current Ratio2,33
Interest Coverage-36,88

Valorisation

PE (TTM|2027)
-1,18 | 28,50
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio1,16
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1366 pairs)
Métrique Action Médiane du Secteur
P/E -1,2 -1,5
P/B 1,2 1,6
ROE % -96,2 -53,6
Net Margin % -44,4 -41,5
Rev Growth 5Y % 4,5 1,8
D/E 0,3 0,3

Objectif de Cours des Analystes

10 analystes
Hold
Actuel
4,35 €
+78.9%
Objectif
7,78 €
4,00 €
7,00 €
18,00 €
Prévisions
P/E Prévisionnel 26,84
BPA Prévisionnel 0,16 €
Croissance BPA (est.) +242,5%
CA Est. 915,10 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 0,16 €
0,03 € – 0,41 €
 915,10 M 12
FY2026 0,05 €
-0,06 € – 0,22 €
 865,81 M 12

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,02 € 0,04 € +348,3%
Q32025 -0,01 € 0,00 € +100,0%
Q22025 -0,01 € 0,05 € +724,2%
Q12025 -0,05 € -0,03 € +44,8%

ETFs Holding This Stock

WDNA WDNA
0,60% weight
GTTUX GTTUX
0,34% weight
GSITX GSITX
0,34% weight
GTTTX GTTTX
0,34% weight
GTTRX GTTRX
0,34% weight
GSXPX GSXPX
0,34% weight
GSATX GSATX
0,34% weight
GSCTX GSCTX
0,34% weight
FSCC logo FSCC Federated Hermes MDT Small Cap Core ETF
0,30% weight
QASCX QASCX
0,28% weight

Dividend History

Ex-Date Payment Date Amount Yield
Jul 01, 2009 — 1,75 € N/A
Jun 15, 2009 — 1,75 € N/A

All Fundamental Metrics
Growth
Revenue Growth (1Y) -1,56% Revenue Growth (3Y) 4,63%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 4,53% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 824,50 M Net Income (TTM) -365,90 M
ROE -96,18% ROA -52,07%
Gross Margin 69,93% Operating Margin -46,96%
Net Margin -44,38% Free Cash Flow (TTM) 1,80 M
ROIC -57,85% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,32 Current Ratio 2,33
Interest Coverage -36,88 Asset Turnover 1,17
Working Capital 196,80 M Tangible Book Value 158,10 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,18 Forward P/E N/A
P/B Ratio 1,16 P/S Ratio 0,52
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0,42%
Market Cap 432,01 M Enterprise Value 406,11 M
Per Share
EPS (Diluted TTM) -3,95 Revenue / Share 8,82
FCF / Share 0,02 OCF / Share 0,02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -0,49%
SBC-Adj. FCF -43,00 M Growth Momentum -6,09

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 824,50 M 837,60 M 753,20 M 678,40 M 690,60 M
Net Income -365,90 M -127,30 M -263,30 M -112,00 M -27,20 M
EPS (Diluted) -3,95 -1,41 -3,18 -1,39 -0,35
Gross Profit 576,60 M 585,40 M — — —
Operating Income -387,20 M -123,50 M -257,40 M -140,60 M -190,50 M
EBITDA — — — — —
R&D Expenses 106,80 M 113,40 M 88,70 M 85,40 M 81,90 M
SG&A Expenses — — 572,90 M 514,70 M 537,80 M
D&A 53,70 M 61,20 M 61,90 M 52,70 M 62,80 M
Interest Expense 10,50 M 2,80 M 2,90 M 3,20 M 6,60 M
Income Tax -29,20 M 3,80 M 1,10 M -28,60 M -29,90 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 706,60 M 1,03 B 1,15 B 1,20 B 1,32 B
Total Liabilities 338,60 M 326,50 M 363,30 M 312,90 M 352,90 M
Shareholders' Equity 368,00 M 701,10 M 783,20 M 885,80 M 967,80 M
Total Debt 119,90 M 39,60 M 38,50 M 0,0 0,0
Cash & Equivalents 149,60 M 102,40 M 132,10 M 56,90 M 258,40 M
Current Assets 332,60 M 298,00 M 313,60 M 274,60 M 484,80 M
Current Liabilities 133,80 M 164,10 M 155,90 M 137,20 M 204,30 M